Adapted Table Tennis for Disabilities
Health Promotion Through Adapted Table Tennis for Individuals With Disabilities
1 other identifier
interventional
40
1 country
1
Brief Summary
In recent years, sports participation among individuals with disabilities has increased, driven by medical advancements, growing societal awareness, and improved accessibility. However, a significant proportion-about 60%-still do not engage in regular physical activity, often due to limited awareness and environmental barriers. Organizations like the International Paralympic Committee (IPC) have played a key role in promoting disability sports, as evidenced by the growth in Paralympic participation from 400 athletes in 1960 to an expected 4,400 in 2024. Physical activity offers both physical and psychological benefits for people with disabilities, including improved cardiovascular health, motor function, and emotional well-being. Although adapted table tennis is a promising, accessible sport for this population, research on its health effects remains limited. This study aims to evaluate the impact of a 12-week adapted table tennis program on the physical and mental health of individuals with disabilities and to explore its potential as a sustainable health-promotion strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2025
CompletedFirst Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
June 26, 2026
June 1, 2026
3 years
July 9, 2025
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Muscle strength
Static grip strength test
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Volume of Forced Vital Capacity (FVC) in Liters
FVC is the total volume of air that can be forcefully and completely exhaled after a full inspiration. It is measured in liters (L) using a digital spirometer. Higher values indicate greater lung volume and better respiratory capacity.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
6-Minute Walk/Push Test (6MWPT) Distance
This outcome measures the maximal distance a participant can travel in 6 minutes on a hard, flat surface. Depending on the participant's ambulatory ability, this was conducted either by walking (6-Minute Walk Test) or by propelling a manual wheelchair (6-Minute Push Test). The total distance is recorded in meters (m). Higher values indicate better cardiopulmonary endurance and functional mobility.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Flexibility
chair sit-and-reach test
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Waist Circumference in Centimeters
Waist circumference will be measured using a flexible, non-stretchable anthropometric tape. The measurement is taken at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest (or at the level of the umbilicus, depending on your exact protocol). The data will be reported as a continuous variable in centimeters (cm). This measurement serves as an indicator of central adiposity and body composition changes.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Total Score on the Generalized Anxiety Disorder 7-Item (GAD-7) Scale
The GAD-7 is a self-administered questionnaire used to assess the severity of generalized anxiety disorder symptoms. It consists of 7 items, with each item scored from 0 (not at all) to 3 (nearly every day). The total aggregated score ranges from 0 to 21. Higher scores indicate greater severity of anxiety symptoms (Score guidelines: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe anxiety).
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2)
Bone Mineral Density (BMD) Assessed by Dual-Energy X-ray Absorptiometry in g/cm^2
Bone mineral density of the whole body (or specific regions such as lumbar spine and femoral neck) will be measured using Dual-Energy X-ray Absorptiometry (DXA). The outcome is reported in grams per square centimeter (g/cm\^2). Higher values indicate stronger, denser bones and a lower risk of osteopenia or osteoporosis.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2)
Number of Participants with Abnormal Blood Laboratory Values
A comprehensive blood panel will be drawn to evaluate general health and physiological safety. The panel includes metabolic markers (HbA1C), lipid profile (Total cholesterol, Triglycerides, HDL, LDL), renal function and electrolytes (BUN, Cr, uric acid, Na, K, Ca, Mg), liver enzymes (GPT, GOT), complete blood count (CBC), albumin, CRP, and Vitamin D. The outcome is reported as the total number of participants exhibiting clinically significant abnormal values outside the standard laboratory reference ranges.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2)
Volume of Forced Expiratory Volume in 1 Second (FEV1) in Liters
FEV1 is the maximal volume of air exhaled in the first second of a forced expiration from a position of full inspiration. It is measured in liters (L) using a digital spirometer. Higher values indicate better pulmonary function and airway patency.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Ratio of FEV1 to FVC (FEV1/FVC)
This outcome calculates the ratio of Forced Expiratory Volume in 1 Second (FEV1) to Forced Vital Capacity (FVC). It is expressed as a percentage (%). It serves as a clinical indicator of airway obstruction, with higher values generally indicating better respiratory mechanics.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Total Lean Body Mass Assessed by Dual-Energy X-ray Absorptiometry (in kg)
Total body lean mass (which includes muscle mass and excludes fat and bone mineral content) will be measured using Dual-Energy X-ray Absorptiometry (DXA). The outcome is reported in kilograms (kg). Higher values indicate greater muscle mass, reflecting positive structural adaptations to the adapted sports intervention.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2)
Percentage of Total Body Fat Assessed by Dual-Energy X-ray Absorptiometry
Total body fat percentage will be measured using Dual-Energy X-ray Absorptiometry (DXA). The outcome is calculated as fat mass divided by total body mass and reported as a percentage (%). This metric is used to evaluate changes in body composition and metabolic health.
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2)
Other Outcomes (7)
Sensory, Motor, and F-wave Latencies of the Median and Ulnar Nerves (in ms)
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Sensory and Motor Nerve Conduction Velocities of the Median and Ulnar Nerves (in m/s)
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
Number of Participants with Upper Limb Neuropathy (Median or Ulnar)
Pre-intervention (T0), after 12 weeks of intervention (T1), and 6 months after intervention (T2).
- +4 more other outcomes
Study Arms (2)
Adapted table tennis training group
EXPERIMENTALThe participants who engage in weekly 2-hour group table tennis sessions for 12 weeks.
Control group
NO INTERVENTIONThe participants who only receive regular medical management without exercise training
Interventions
Under the guidance of a professional adapted sports coach, participants in the experimental group will engage in weekly 2-hour group table tennis sessions for 12 weeks. The sessions will include warm-up exercises, basic table tennis techniques, skill practice, and cool-down stretching exercises.
Eligibility Criteria
You may qualify if:
- Individuals aged 18 to 75 years who hold a disability identification certificate issued by the Taiwan government and have been assessed by a physician and a professional coach as suitable for participating in adapted table tennis, with a willingness to take part in the study; Participants must respond "No" to all questions in the first section of the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+ 2024 edition) or, if they respond "Yes" to one or more questions in the first section, must respond "No" to all questions in the second section.
You may not qualify if:
- Individuals with uncontrolled cardiovascular diseases or relevant neurological history.
- Hearing impairment.
- Cognitive dysfunction.
- Individuals with uncontrolled psychiatric disorders who are unable to comply with the assessments.
- Individuals with color vision deficiencies or visual impairments.
- Pregnant women (self-reported).
- Individuals who have undergone lower limb musculoskeletal surgery or experienced musculoskeletal injuries within the past 6 months.
- Individuals with a history of significant head trauma.
- Individuals unable to comply with the testing schedule.
- Individuals advised by a physician to avoid moderate to high-intensity exercise or those deemed unsuitable for physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807, Taiwan
Study Officials
- STUDY CHAIR
Chia-Ling Lee, MD
Kaohsiung Medical University Chung-Ho Memorial Hospital, Physical and Rehabilitation Medicine Department
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2025
First Posted
June 26, 2026
Study Start
July 8, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
June 26, 2026
Record last verified: 2026-06